John Gourary

Head, Covington & Burling

John Gourary heads Covington’s Royalty Monetization practice and is widely recognized as the leading practitioner in the highly specialized field of pharmaceutical royalty monetizations (both classic royalty monetizations and synthetic royalty monetizations).

John has been involved in the royalty monetization market from its early stages, has advised on transactions with an aggregate value of over $10 billion, and has participated in virtually all of the landmark transactions in this unique area.

John is also especially well-known for his representations of major universities and non-profit institutions in their royalty monetizations.

John's clients include Blackstone Life Sciences, Boston Children's Hospital, Canada Pension Plan Investment Board, Cold Spring Harbor Laboratory, Dana-Farber Cancer Institute, Duke University, Emory University, LifeArc, Northwestern University, Pfizer, Sagard Healthcare Royalty Partners, Takeda, The Kennedy Trust for Rheumatology Research, The Walter and Eliza Hall Institute of Medical Research, University of Colorado, University of Newcastle upon Tyne, University of Pennsylvania, and University of Rochester.

John also has extensive experience with all kinds of bank finance transactions (including syndicated loans, acquisition finance, structured finance, and innovative financings of unusual asset classes).